Wednesday, August 26, 2026
DeepMind spinout just embarrassed OpenAI & Anthropic
Inherent, a DeepMind spinout, just dropped a tiny AI agent that beats both OpenAI and Anthropic at replicating scientific research (bold move for a new player), while Nvidia eyes a massive $30B+ investment in Perplexity with a tech licensing sweetener. Meanwhile, one startup is training AI on actual living human skin tissue for a month at a time to discover cosmetic ingredients (yikes). So here's the thing: when a scrappy startup outperforms the giants at research replication, are we finally seeing the democratization of frontier AI, or just better benchmarking?
Top Stories
TechCrunch
DeepMind alumni-founded Inherent claims its AI agent Faraday outperformed much larger models from Anthropic and OpenAI at replicating scientific research, using a fraction of the computing power by employing reinforcement learning to develop "research taste." The startup, which raised $50 million in seed funding, aims to build AI systems capable of discovering new scientific knowledge.
Bloomberg
SoftBank is preparing a record-breaking ¥1 trillion retail bond offering in Japan, the largest such sale in the country's history, as it seeks capital for AI and technology investments.
The Information
Nvidia is discussing investing in AI search startup Perplexity at a $30+ billion valuation, more than triple its previous $9 billion valuation, potentially including both equity investment and a technology licensing deal.
TechCrunch
Outer Biosciences keeps living human skin tissue viable for over a month and uses AI to rapidly discover new cosmetic ingredients, generating candidates every six weeks compared to the industry's 18-month timeline. The startup has raised $23 million and plans to license its discoveries rather than build consumer products directly.
Thinking Machines launched a $50,000 grant program to fund safety research on open-weight AI models, focusing on tamper-resistant safeguards, hazardous data filtering, differential defensive capabilities, and measuring worst-case risks after model release.
Keep Reading
Industry Voices
Edward Hughes
Co-founder and Chief Scientist at Inherent
Former DeepMind researcher who led work on open-ended learning and multi-agent systems, now building AI that can discover its own curricula at Inherent.
Michael Polansky
Co-founder at Outer Biosciences
Co-founder using AI to engineer longevity therapeutics by mapping cellular aging pathways at Outer Biosciences.
Enjoyed this issue?
Get daily AI intel delivered to your inbox. No fluff, just the stories that matter.